Sonova Holding AG (SONVY) Stock Price & Analysis
Sonova Holding AG (SONVY) — price $69.42 (+0.39%), as of the Nov 19, 2026 trading session; market cap $20.7B.
Educational signal · not a buy or sell recommendation · How to read this
Sonova Holding AG · SONVY · Healthcare · Medical - Devices
Sonova Holding AG is a prominent developer, manufacturer, and global distributor of hearing health solutions for all age groups.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $69.42 | |
| Change on the day | +0.39% | |
| 52-week range | $42.26–$71.91 | |
| Market capitalisation | $20.7B | — |
| Price / earnings (trailing) | 34.69 | |
| Shares traded on the day | 711 | |
| Beta (volatility vs the S&P 500) | 1.09 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Sonova Holding AG (SONVY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Sonova Holding AG (SONVY), and what does it report?
Short answer
Sonova Holding AG is a prominent developer, manufacturer, and global distributor of hearing health solutions for all age groups. Healthcare / Medical Devices Headquarters: Laubisrutistrasse 28, Stäfa, ZH, 8712, CH. It employs 18,447 people and is led by Eric Alain Bernard. In Q2 FY2027 it reported revenue of CHF 1.84B and net income of CHF 252M. The market values it at $20.7B.
What do the latest results show for Sonova Holding AG (SONVY)?
Short answer · as of
The most recent reported quarter, Q2 FY2027, carried revenue of CHF 1.84B. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2027 | CHF 1.84B | CHF 252M | CHF 0.84 (diluted) |
| Q4 FY2026 | CHF 1.79B | CHF 243M | CHF 0.82 (diluted) |
| Q2 FY2026 | CHF 1.78B | CHF 185M | CHF 0.62 (diluted) |
| Q4 FY2025 | CHF 2.03B | CHF 332M | CHF 1.11 (diluted) |
What are the financial strengths and risks for Sonova Holding AG (SONVY)?
Short answer · as of
The distress and quality screens read Altman Z 5.41 · Piotroski F 8. Trailing ratios: ROE 18.3% · ROA 8.3% · current ratio 1.69 · earnings yield 2.9% · free-cash-flow yield 4.0%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SONVY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SONVY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Sonova Holding AG (SONVY) — Healthcare
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
What does Phonak contribute to Sonova?
Phonak is a core hearing-instrument brand within Sonova’s portfolio. Its products are distributed alongside other hearing brands through independent partners and the wider hearing-care ecosystem.
Why does Advanced Bionics matter to Sonova’s outlook?
Advanced Bionics carries Sonova’s cochlear implant offering. Management has linked expected performance improvement to a planned new sound processor, making product execution in this business especially important.
How does Sennheiser change Sonova’s business mix?
Sennheiser adds consumer headphones, hearables, microphones, and wireless transmission products to a group otherwise centered on hearing care and implants. Sonova is therefore exposed to consumer-audio demand as well as clinical hearing needs.
Why does institutional ownership look sparse for SONVY?
The reported filing-based ownership record contains a limited holder set, with Rhumbline Advisers the largest disclosed holder. The listing is on the over-the-counter market, so this record should be read as the reported footprint for SONVY rather than a complete map of Sonova’s global shareholder base.
What is the SONVY stock price today?
The last price recorded for Sonova Holding AG (SONVY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com